Dena Hayes

Cardiology fellow @nyulangone @BellevueHosp | IM @nyulangoneBK

[Brian Wayda @brian_wayda]

Little late on this post, but figured I’d share with all 10 of my followers… 😅

Awesome work by our trainees at THT this year. Much more to come

@GolombeckMD @NehaParvMD @Caroline_Magro1 @DHayesMD @jliebs95 @MarziaLeacche @RandyGoldbergMD
@StephanieGolob @ArushiSinghMD

[Bernard Kadosh @KadoshBernard]

Calling all🫀AHFTC and purveyors of #critcarecards
Now that #ACC26 is over, come spend a weekend in NYC at the nation's #1 cardiac hospital to learn about what's new and exciting #CardiogenicShock #Transplant #LVAD #TAH and more! ONE month away. 🗣 Tell your friends!️
✍️Register now: https://t.co/billoxeDrX

Check out this lineup!
@ReyentovichHFMD @CarineHamo
@JasonKatzMD @SVRaoMD

#ISHLT2026 #Cardiology #CardioTwitter #CardioX #MedX #FITs #WIC #HeartFailure

[Dena Hayes @DHayesMD]

Thank you @ACCinTouch for the opportunity to share our work on Cardiac Amyloidosis on Septal Myectomy Specimens of Patients with HCM

🫀1.6% (9/565) had amyloidosis on pathology - TTR, AL, AA
🫀 Findings suggest coexistence of HCM + amyloidosis in some pts

@danmassera #ACC2026

[Dena Hayes @DHayesMD]

Enjoyed discussing national trends in heart transplantation in adults ≥70 at #THT2026

✅ >90% of programs performed HT in ≥70
📊 Marked variability across centers & UNOS regions
❌ No correlation with center volume

Future direction: identifying which ≥70 benefit most

[Dena Hayes @DHayesMD]

@ArushiSinghMD @brian_wayda

[Dena Hayes @DHayesMD]

Persistently elevated donor-derived cell-free DNA without rejection? 👀

@GolombeckMD highlights patients with chronically elevated cfDNA of unclear etiology, raising questions about management

Prospective studies needed to define why & how to manage

#THT2026 #ddcfDNA

[Dena Hayes @DHayesMD]

During the Valvular Shock session 3/4 cases involved nonagenarians, reflecting shifting demographics of transcatheter valve population

Great discussion on complexity of care as patient age ⬆️ & transcatheter options expand, esp when advanced therapies aren’t an option #THT2026

[Dena Hayes @DHayesMD]

Excited to be a Social Media Ambassador for #THT2026 — I’ll be sharing highlights throughout the meeting!

[Cardiovascular Research Foundation @crfheart]

Your inside look at #THT2026 starts here! 🔥

Follow our Ambassadors for key updates, expert insights, and behind the scenes action from the conference’s biggest sessions. https://t.co/an4jiOId0k

👉 @SophiaAirhartMD @michel_helou @RohangantiMD @igor_igorgosev @AHajduczok @DHayesMD @Ibrahim_Kamel9 @dor_lotan @DavidMajureMD @Nikhil15 @SomPSingh

#heartfailure #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @HFSA @asaiojournal @ISHLT @JCardFail

[Dena Hayes @DHayesMD]

Strain imaging by TTE and CMR:
🫀Detects subclinical LV dysfunction
🫀Reveals disease-specific patterns (amyloidosis, HCM, etc)
🫀Adds prognostic value across the LVEF spectrum
🫀Identifies CTRCD & informs cardioprotective therapy

[Dena Hayes @DHayesMD]

Check out our review article on Strain Imaging in Heart Failure @drmishbloom @JStojanovskaMD

https://t.co/TcmLM9krNu

[Dena Hayes @DHayesMD]

@JACCJournals @MinnowWalsh Thank you @MinnowWalsh! Really enjoyed talking with you about our case

[Sunil V. Rao @SVRaoMD]

Do all post PCI pts need the same obs period?

Fantastic study by Dr. Joey Lerner @nyulangone Cardiology fellow showing that individualized milestone-based observation reduces LOS!

[Dena Hayes @DHayesMD]

Learning about PA catheter insertion from the best @valenjaramillo7 @carlosalviar #ACC25

[Dena Hayes @DHayesMD]

Check out this fascinating case of cardiac sarcoidosis presenting as a biatrial mass at #ACC25 today & simultaneous publication in @JACCJournals 🫀🔬
@RandyGoldbergMD @DanyaalMoinMD @albertjungmd

https://t.co/zOn1wG5GFH

[Michelle Kittleson MD PhD @MKIttlesonMD]

Vutrisiran, a TTR silencer, is now FDA-approved for transthyretin cardiac amyloidosis- along w/two FDA-approved stabilizers, tafamidis and acoramidis.

There is no trial evidence to guide single vs combo therapy.

What will be your go-to regimen for ATTR-CM? Explain in comments!

[Navjot Kaur Sobti, MD @doctornavjot]

Absolutely loved running into my @ACCinTouch #WIC mentee in between TAVRs @DHayesMD, now cardiology fellow🫀❤️ on her Cath Lab rotation @nyulangone @nyugrossman! Looking forward to taking care of valve patients together. #WomenInCardiology #ACCFIT #StructuralFellow @WomenAs1

[Dena Hayes @DHayesMD]

@doctornavjot @ACCinTouch @nyulangone @nyugrossman @WomenAs1 Love this!! Looking forward to many more run ins 😊🫀

[CORE IM @COREIMpodcast]

1/ You are consulted overnight for a 66M found hypothermic and unresponsive in his home…

Time for #12LeadThursday 🫀⤵️

📺: https://t.co/NYxIXROhmr
🖥️: https://t.co/IZ9cZmqaKL

[JACC Journals @JACCJournals]

#GDMT use has increased over time

2/5 patients did not receive all recommended #HeartFailure medications at discharge

Reduced likelihood of receipt in:
🔸 Women
🔸 Minority patients
🔸 Urban hospitals

📎 https://t.co/ZvzJH0cHZd

#JACCHF @paheidenreich @UREssien @StanSwatMD

[Stephanie Golob @StephanieGolob]

@DHayesMD presenting on transbrachial biopsy for heart transplant rejection surveillance
Takeaways:
1-safe
2-shorter procedure time
3-preferred by patients
@amitalamMD @ReyentovichHFMD @KadoshBernard @RandyGoldbergMD